Autoimmune Skin Diseases encompass a group of conditions where the body's immune system mistakenly attacks healthy skin cells, leading to inflammation, tissue damage, and various skin manifestations. Examples include psoriasis, lupus erythematosus, dermatomyositis, pemphigus vulgaris, and bullous pemphigoid, among others. Psoriasis is characterized by red, scaly patches on the skin, commonly affecting the elbows, knees, scalp, and lower back. Lupus erythematosus can cause a butterfly-shaped rash on the face, as well as lesions on other parts of the body, often triggered by sun exposure. Dermatomyositis presents with a distinctive rash, often accompanied by muscle weakness and inflammation. Pemphigus vulgaris and bullous pemphigoid are blistering disorders where the immune system targets proteins within the skin, leading to painful blisters and erosions. Treatment for autoimmune skin diseases typically involves a combination of topical medications, systemic therapies such as corticosteroids or immunosuppressants, and phototherapy. Biologic agents that target specific components of the immune system have also shown effectiveness in managing these conditions. Managing autoimmune skin diseases requires a multidisciplinary approach involving dermatologists, rheumatologists, and other healthcare professionals. Treatment aims to alleviate symptoms, reduce inflammation, and prevent complications while improving the patient's quality of life. Lifestyle modifications, such as avoiding triggers like stress, certain medications, and sun exposure, may also help manage symptoms and reduce flare-ups. Additionally, ongoing research into the underlying mechanisms of autoimmune skin diseases is essential for developing more targeted and effective treatments in the future.
Title : Paraneoplastic autoimmune multiorgan syndrome or PAMS: Paraneoplastic pemphigus revisited
Sergei A Grando, University of California Irvine, United States
Title : Modern non-invasive methods for in vivo assessment of skin
Georgios N Stamatas, SGS, France
Title : Personalized and precision dermatology through the view of biodesign-inspired translational & data-driven applications: Revolutionary skin treatments for every concern in clinical dermatology integrating skin care experts and consumers
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : The next generation of threads: Lifting, volumization, and biostimulation in one powerful triple action
George Sulamanidze, Plastic Surgeon at Clinic of Plastic and Aesthetic Surgery and Cosmetology TOTALCharm, Georgia
Title : Lymphoproliferative diseases in the practice of a dermatologist
Irina Sergeeva, Novosibirsk State University, Russian Federation
Title : Comparative efficacy of omalizumab and dupilumab in children with Chronic Spontaneous Urticaria (CSU): A retrospective cohort analysis
Molynna Nguyen, University of Toledo, United States
Title : "Mirror mirror on the skin” — A low-cost community strategy to reduce melanoma disparities in Washington, D.C.
Kayla Sampson, Georgetown University School of Medicine, United States
Title : Vitiligo: Not just an aesthetic disorder
Mateja Starbek Zorko, University Medical centre Ljubljana, Slovenia
Title : Personalized and precision medicine as a unique avenue to have the healthcare model renewed to secure the national biosafety: Advanced skincare solutions in individualized cosmetology, reconstructive plastic surgery and the modern beauty
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Keratinocyte apoptosis by caspase – 3 Immunostaining in histopathology as marker of activity as well as correlation with dermoscopy findings in Cutaneous Lupus Erythematosus (CLE) in skin of color: An observational study.
Subhojit Ray, All India Institute of Medical Sciences, India